Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis

Por Barraco, D, Lasho, T L, Gangat, N, Finke, C, Elala, Y C, Pardanani, A, Tefferi, A
Publicado no Blood Cancer J (2016)

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

Por Barraco, D, Cerquozzi, S, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N, Tefferi, A
Publicado no Blood Cancer J (2017)

Liver function test abnormalities and their clinical relevance in primary myelofibrosis

Por Barraco, D, Mudireddy, M, Shah, S, Hanson, C A, Ketterling, R P, Gangat, N, Pardanani, A, Tefferi, A
Publicado no Blood Cancer J (2017)

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Por Cerquozzi, S., Barraco, D., Lasho, T., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A., Gangat, N., Tefferi, A.
Publicado no Blood Cancer J (2017)

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

Por Barraco, D, Elala, Y C, Lasho, T L, Begna, K H, Gangat, N, Finke, C, Hanson, C A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado no Blood Cancer J (2016)

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

Por Barraco, D, Elala, Y C, Lasho, T L, Begna, K H, Gangat, N, Finke, C, Hanson, C A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado no Blood Cancer J (2016)